Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
531-02-012 / 531-02-012 ISMRM Abstract

Cerebral Perfusion and Glymphatic Function Alterations in Chronic Thromboembolic Pulmonary Hypertension

Primary: Neuro - Stroke and Cerebrovascular Disorders
Secondary: Contrast Mechanisms - Perfusion
531-02-012 · Imaging Neurodegeneration in Motion: Multimodal Biomarkers for Alzheimer’s Disease and Parkinson’s Disease · Wednesday, 13 May, 1:40 PM–3:16 PM · Roof Terrace
531-02-012 · Imaging Neurodegeneration in Motion: Multimodal Biomarkers for Alzheimer’s Disease and Parkinson’s Disease · Wednesday, 13 May, 1:40 PM–3:16 PM · Roof Terrace
Keywords: Glymphatics Flow Perfusion Arterial Spin Labelling (ASL) Cerebrovascular disease
Accepted
Shiyu Qi 1, Tong Yuan1, Penghui Sun1, Yifei Zhang2, Jianfeng Wang3, Juanni Gong4, Xiuqin Jia1, Qi Yang1
1Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University, beijing, China
2MR Research China, GE Healthcare, Beijing, China
3Department of Interventional Medicine, Beijing Chaoyang Hospital, Capital Medical University, beijing, China
4Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, beijing, China
Presenting Author: Shiyu Qi

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Malenfant S, Brassard P, Paquette M, et al. Compromised Cerebrovascular Regulation and Cerebral Oxygenation in Pulmonary Arterial Hypertension[J/OL]. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017, 6(10): e006126.doi:10.1161/JAHA.117.006126. [doi]
2. Delcroix M, Lang I, Pepke-Zaba J, et al. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry[J/OL]. Circulation, 2016, 133(9): 859-871.doi:10.1161/CIRCULATIONAHA.115.016522. [doi]
3. Xie L, Zhang Y, Hong H, et al. Higher intracranial arterial pulsatility is associated with presumed imaging markers of the glymphatic system: An explorative study[J/OL]. NeuroImage, 2024, 288: 120524.https://doi.org/10.1016/j.neuroimage.2024.120524. [doi]
4. Han F, Chen J, Belkin-Rosen A, et al. Reduced coupling between cerebrospinal fluid flow and global brain activity is linked to Alzheimer disease–related pathology[J/OL]. PLoS Biology, 2021, 19(6): e3001233.https://doi.org/10.1371/journal.pbio.3001233. [doi]
5. Leoni RF, Paiva FF, Henning EC, et al. Magnetic Resonance Imaging Quantification of Regional Cerebral Blood Flow and Cerebrovascular Reactivity to Carbon Dioxide in Normotensive and Hypertensive Rats[J/OL]. NeuroImage, 2011, 58(1): 75-81.doi:10.1016/j.neuroimage.2011.06.030. [doi]
6. Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension[J/OL]. European Heart Journal, 2022, 43(38): 3618-3731.https://doi.org/10.1093/eurheartj/ehac237. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/531-02-012